Evidence map›Paper›PMID 41029331›Full record

ArticleBMC cancer2025

Predictive value of

Bangyu Liang, Ziyue Na, Kezheng Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Bangyu Liang *Department of PET/CT, Harbin Medical University Cancer Hospital, Harbin, China.
Ziyue Na *Department of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, China.
Kezheng WangDepartment of PET/CT, Harbin Medical University Cancer Hospital, Harbin, China. wangkezheng9954001@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study is to investigate the feasibility of using the MATERIALS AND

methodsPatients with GC who underwent

results62 patients (44 males and 18 females; age range 30-81 years-old, median age 65.5 years-old) were finally included. There were 20 patients in MSI group and 42 patients in MSS group. MTV

conclusion

Indexed as

Fluorodeoxyglucose F18Microsatellite InstabilityPositron Emission Tomography Computed TomographyStomach NeoplasmsAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedPredictive Value of TestsRadiopharmaceuticalsRetrospective StudiesROC CurveFluorodeoxyglucose F18RadiopharmaceuticalsGastric cancerMetabolic tumor volumeMicrosatellite instabilityMicrosatellite stabilityPET/CTTotal lesion glycolysis

Identifiers

PMID41029331
PMCPMC12482397

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.